Prosecution Insights
Last updated: April 19, 2026

Amo Pharma Ltd.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18134955 METHODS OF TREATING PHELAN MCDERMID SYNDROME USING FARNESYL DIBENZODIAZEPINONES CORNET, JEAN P 1628 Non-Final OA Apr 14, 2023
18108320 METHOD OF TREATING RNA REPEAT MEDIATED DISEASES WITH RNA REPEAT BINDING COMPOUND SCHMITT, MICHAEL J 1629 Non-Final OA Feb 10, 2023

Managing Amo Pharma Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month